Phase II Clinical Development of New Drugs

by Joseph C. Cappelleri, Ding-Geng Chen, Shuyen Ho, et al.

Book Overview

Chapter 1 Introduction.- Chapter 2 Concept of Alpha.- Chapter 3 Confirmation and Exploration.- Chapter 4 Design a Proof of Concept (PoC) Trial.- Chapter 5 Design of Dose-Ranging Trials.- Chapter 6 Combining PoC and Dose Ranging Trials.- Chapter 7 Risks of Inconclusiveness.- Chapter 8 Analysis of a PoC Study.- Chapter 9 Data Analysis for Dose-Ranging Trials with Continuous Outcome.- Chapter 10 Data Analysis of Dose-Ranging Trials for Binary Outcomes.- Chapter 11 Bayesian Methods.- Chapter 12 Overview of Phase III Clinical Trials.

• Format: Paperback
• Language: English
• ISBN: 9811350744
• ISBN13: 9789811350740
• Release Date: December 2018
• Publisher: Springer
• Length: 241 Pages
• Weight: 0.81 lbs.
• Dimensions: 0.6" x 6.1" x 9.2"